Sign in to view content

Time to Retinal Fluid Control With Faricimab vs Aflibercept in Patients With DME in the Phase 3 YOSEMITE/RHINE Trials

Aleksandra V. Rachitskaya, MD, FASRS

Video
Published 2023

Related

Episode 143: Journal Club, Pediatric Retinal Detachment Surgery, Open Label Extension RISE and RIDE, BP Changes during Injections
Jayanth Sridhar, MD
Member Podcasts
2018
Protocol T Extension Results
John A. Wells, MD, FACS
Updates from the Field
2019
Protocol U: Short-Term Evaluation of Combination Dexamethasone + Ranibizumab vs. Ranibizumab Alone for Persistent Central-Involv
Raj K. Maturi, MD
Updates from the Field
2017

Category: Diabetic Retinopathy

See more